Ra Medical Systems, Inc. (RMED) financial statements (2022 and earlier)

Company profile

Business Address 2070 LAS PALMAS DRIVE
CARLSBAD, CA 92011
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15,04520,61620,22015,95423,90633,64629,380
Cash and cash equivalents15,04520,61620,22015,95423,90633,64629,380
Receivables2117228160238475474
Inventory, net of allowances, customer advances and progress billings9869972,3232,2492,2182,5922,704
Inventory9869972,3232,2492,2182,5922,704
Deferred costs  8437 281231
Other undisclosed current assets1,0371,1691,2221,5181,258185990
Total current assets:17,08922,79924,07719,91827,62037,17933,779
Noncurrent Assets
Operating lease, right-of-use asset2,1102,2052,3002,3932,4842,5742,662
Property, plant and equipment1,8092,0302,6612,8203,2113,5814,106
Other noncurrent assets3645121131123120144
Total noncurrent assets:3,9554,2805,0825,3445,8186,2756,912
TOTAL ASSETS:21,04427,07929,15925,26233,43843,45440,691
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,1073,1753,0983,1904,9195,4905,807
Accounts payable9885431,0779775718991,870
Accrued liabilities4,1192,6322,0212,2134,3484,5913,937
Deferred revenue  1,7871,7771,8011,7291,859
Debt   674421168 
Other undisclosed current liabilities283301320338621652638
Total current liabilities:5,3903,4765,2055,9797,7628,0398,304
Noncurrent Liabilities
Long-term debt and lease obligation1,9812,0542,1252,1952,2642,3552,445
Operating lease, liability1,9812,0542,1252,1952,2642,3552,445
Liabilities, other than long-term debt  500617686656846
Deferred revenue  500617686656846
Other undisclosed noncurrent liabilities(1,981)(2,054)661,3261,5791,8662,112
Total noncurrent liabilities: 2,0542,6914,1384,5294,8775,403
Total liabilities:7,3715,5307,89610,11712,29112,91613,707
Stockholders' equity
Stockholders' equity attributable to parent13,67321,54921,26315,14521,14730,53826,984
Common stock8777774
Additional paid in capital191,937191,527186,943175,576174,342173,289161,959
Accumulated deficit(178,272)(169,985)(165,687)(160,438)(153,202)(142,758)(134,979)
Total stockholders' equity:13,67321,54921,26315,14521,14730,53826,984
TOTAL LIABILITIES AND EQUITY:21,04427,07929,15925,26233,43843,45440,691

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues551,0051,1181,217914900
Cost of revenue
(Cost of Goods and Services Sold)
(347)(246)(1,488)(1,373)(1,313)(1,418)(1,167)
Gross profit:(342)(241)(483)(255)(96)(504)(267)
Operating expenses(7,922)(7,153)(6,759)(6,930)(10,288)(7,265)(9,849)
Operating loss:(8,264)(7,394)(7,242)(7,185)(10,384)(7,769)(10,116)
Nonoperating income (expense)(19)161,993(51)(53)(10)(5)
Investment income, nonoperating  111410
Other nonoperating income (expense)(19)16     
Interest and debt expense  2,023(52)(54)(14)(15)
Loss from continuing operations before equity method investments, income taxes:(8,283)(7,378)(3,226)(7,288)(10,491)(7,793)(10,136)
Other undisclosed income (loss) from continuing operations before income taxes  (2,023)52541415
Loss from continuing operations before income taxes:(8,283)(7,378)(5,249)(7,236)(10,437)(7,779)(10,121)
Other undisclosed loss from continuing operations(4)   (7)  
Loss from continuing operations:(8,287)(7,378)(5,249)(7,236)(10,444)(7,779)(10,121)
Income from discontinued operations 3,080     
Net loss available to common stockholders, diluted:(8,287)(4,298)(5,249)(7,236)(10,444)(7,779)(10,121)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(8,287)(4,298)(5,249)(7,236)(10,444)(7,779)(10,121)
Other comprehensive loss      (4)
Comprehensive loss, net of tax, attributable to parent:(8,287)(4,298)(5,249)(7,236)(10,444)(7,779)(10,125)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: